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Comparison of Percutaneous Coronary Intervention 
versus Coronary Artery Bypass Grafting for 
Unprotected Left Main Coronary Artery Disease at 
National Cardiovascular Centre Harapan Kita
Jajang Sinardja, Yoga Yuniadi, Doni Firman
Background. Despite many studies had been done comparing the outcome 
of Percutaneous Coronary Intervention (PCI) versus Coronary Artery By-
pass Grafting (CABG) in Unprotected Left Main Coronary Artery Disease 
(ULMCAD), there is none such study in Indonesia.
Aim. To compare the outcome of PCI versus CABG in ULMCAD patients 
at National Cardiovascular Centre Harapan Kita (NCCHK) Jakarta.
Methods. A retrospective cohort study was done including 137 ULMCAD 
NCCHK patients who underwent PCI (n = 67) or CABG (n = 70) from July 
2008 until March 2010. One-year Major Adverse Cardio Cerebrovascular 
Event (MACCE) outcome as defined by death, myocardial infarction (MI), 
stroke, and target vessel revascularization (TVR), were evaluated using 
Chi-square analysis, while Kaplan-Meier and Cox regression analysis were 
used to examine the survival curve of the mentioned intervention.
Results. One-year risk of composite MACCE (death, stroke, and TVR) 
(hazard ratio (HR): 1.267; 95% confidence interval (CI): 0.567 – 2.829, p 
= 0.564), and the risk of death (HR: 1.080; 95% CI: 0.405 – 2.878, p = 
0.878) were not significantly different for patients undergoing PCI versus 
CABG. Proportion of stroke was significantly higher in the CABG group 
(8.6% vs 0.0%; p = 0.014), while proportion of  TVR was significantly 
higher in the PCI group (13.4% vs 0.0%; p = 0.001). No MI event was 
documented in both groups. 
Conclusion. During one-year follow up, PCI showed similar rate of 
composite MACCE and death, but higher TVR as compared to CABG 
in ULMCAD patients. Meanwhile CABG showed higher stroke rate as 
compare to PCI.
(J Kardiol Indones. 2011;32:86-95)
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Coronary artery bypass grafting (CABG) is still re-
garded as the standard treatment for unprotected left 
main coronary artery disease (ULMCAD).1  ESC 
Latar Belakang. Walaupun telah banyak studi dilakukan untuk membandingkan keluaran Intervensi Koroner Perkutan (IKP) 
dengan Bedah Pintas Koroner (BPK) pada pasien Unprotected Left Main Coronary Artery Disease (ULMCAD), studi serupa 
belum pernah dilakukan di Indonesia.
Tujuan. Membandingkan keluaran dari IKP dengan BPK pada pasien ULMCAD di Pusat Jantung Nasional Harapan Kita 
(PJNHK), Jakarta.
Metode. Telah dilakukan studi kohort retrospektif terhadap 137 pasien ULMCAD di PJNHK yang menjalani IKP (n = 67) 
atau BPK (n = 70) dari Juli 2008 sampai Maret 2010. Keluaran Kejadian Kardio Serebrovaskular Mayor (KKSM) Satu-Tahun 
sebagaimana didefinisikan sebagai kematian, infark miokard, stroke, dan target vessel revascularization (TVR), dievaluasi meng-
gunakan analisa Kai kuadrat, sementara Kaplan-Meier dan analisa regresi Cox digunakan untuk menilai kurva kesintasan dari 
kedua tindakan tersebut.
Hasil. Resiko satu tahun dari gabungan KKSM (kematian, stroke, dan TVR) (hazard ratio (HR): 1.267; 95% interval keper-
cayaan (IK): 0.567 – 2.829, p = 0.564), dan resiko kematian (HR: 1.080; 95% IK: 0.405 – 2.878, p = 0.878) tidak berbeda 
bermakna pada pasien yang menjalani IKP dibandingkan BPK. Proporsi stroke lebih tinggi secara bermakna pada kelompok 
BPK (8.6% vs 0.0%; p = 0.014), sedangkan proporsi TVR lebih tinggi bermakna pada kelompok IKP (13.4% vs 0.0%; p = 
0.001). Tidak ada kejadian infark miokard pada kedua kelompok. 
Kesimpulan. Dalam satu tahun pengamatan, IKP menunjukkan angka gabungan KKSM yang sama, tetapi angka TVR 
lebih tinggi dibandingkan dengan BPK pada pasien ULMCAD. Sementara itu BPK menunjukkan angka stroke lebih tinggi 
dibandingkan dengan IKP.
(J Kardiol Indones. 2011;32:86-95)
Kata kunci: Intervensi Koroner Perkutan, Bedah Pintas Koroner, Unprotected Left Main Coronary Artery Disease, Kejadian 
Kardio Serebrovaskular Mayor Satu-Tahun.
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guidelines on PCI stated that ‘Stenting for ULM-
CAD should only be considered in the absence of 
other revascularization options.’2  This might be true 
in the era of angioplasty (POBA) or bare metal stents 
(BMS),3-4 but with the emerging of drug-eluting stents 
(DES) era, with the promise of vastly reduced rate of 
restenosis, the possibility of improved late outcomes 
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in this challenging patient group had raised consid-
eration that PCI might have a greater role in treating 
ULMCAD patients.5-6 Bunch of available data support 
continued use and study of PCI, especially using DES, 
in ULMCAD patients with suitable anatomy who are 
either at high risk for CABG or are strongly adverse to 
surgery.7-16 Though, some of those studies were done in 
Asia, most were done in Mongoloid population, and 
very limited data available for non-Mongoloid Asian 
population.7,12,16
At National Cardiovascular Centre Harapan Kita 
(NCCHK), Jakarta, CABG was also the standard 
treatment for ULMCAD, but yet the proportion of 
ULMCAD patients who didn’t undergo CABG were 
quite high, due to patient’s preference or high risk 
profile for CABG. In such cases, PCI was frequently 
considered as an alternative treatment.
This study aimed to compare the outcome of PCI 
versus CABG in ULMCAD patients at NCCHK, 
since there was no such study had been done in Indo-
nesia. The end points of the study were Major Adverse 
Cardiac Cerebrovascular Event (MACCE) which 
were defined as death, myocardial infarction (MI), 
stroke and target vessel revascularization (TVR). 
Methods
Study population. This was a retrospective cohort 
study including 137 ULMCAD patients who under-
went revascularization procedure, either PCI (n = 67) 
or CABG (n = 70) between July 2008 and March 2010 
at NCCHK, Jakarta, Indonesia. Left main coronary 
artery (LMCA) disease was defined as 50% or more 
of stenosis either at ostial/mid and or distal/bifurca-
tion of LMCA, and was considered unprotected if 
there were no patent grafts either to the left anterior 
ascending (LAD) or left circumflex (LCX) coronary 
arteries.17 Patients with previous CABG history, and 
who underwent concomittant valvular surgery were 
excluded from this study.
Data were collected from medical record and or 
by phone. Data including clinical and angiographical 
data. To evaluate severity of vessels disease we used 
SYNTAX scoring, as had been described elsewhere.18 
All patients were followed up until one year after 
revascularization procedure. The end points of the 
study were MACCE which were defined by death, 
MI, stroke, or TVR. Death was defined as death 
from any cause. MI was defined as documented event 
of hospitalization due to diagnosis of ST elevation 
MI (STEMI). Stroke was considered if there was 
any neurological deficits after the revascularization 
procedure, which confirmed by a neurologist. TVR 
was defined as any repeat revascularization procedure 
in any segment of left coronary arteries, either LM, 
LAD or LCX.16
Patients underwent PCI, instead of CABG, be-
cause of either the patient’s or physician’s preference 
or the high risk associated with CABG. All procedures 
were done with standard interventional techniques 
under operator’s discretion.
Statistical analysis. Data were expressed as means ± 
SD. Baseline characteristics of different patient cat-
egories were compared using Student t tests or Mann-
Whitney for continuous variables and Chi-squared 
tests for categorical variables. 
Event-free survival curves were estimated by the 
Kaplan-Meier method and compared using the log-
rank test. The Cox proportional hazards regression 
model was used to determine which variables were 
related significantly to MACCE. Each variable was 
first tested in univariate analysis and then retested after 
adjustments for possible confounders. Variables with p 
values < 0.2 in the univariate Cox regression analysis 
were used in the multivariate Cox regression analysis. 
Differences were considered statistically significant at 
the two-sided p < 0.05 level. All statistical analyses were 
performed using SPSS statistical software, version 17.0 
(Chicago, Illinois).
Results
Patient characteristics. The baseline characteristics 
of the study patients are shown in Table 1. Of 137 
patients included in this study from July 2008 until 
March 2010, most were men (89.8%) with mean age 
of 60 years old. Sixty seven patients were treated with 
PCI, while 70 patients were treated with CABG.
The CABG patients showed a higher clinical and 
angiographical risk profile as compared to the PCI 
patients, as were indicated by significantly higher 
diabetes (52.9% vs. 32.8%; p = 0.018), extent of ves-
sel disease (p = 0.001), involvement of right coronary 
artery (RCA) (p < 0.001), and higher SYNTAX score 
(37.9 vs. 30.6; p < 0.001). However, patients who had 
previous PCI were higher in the PCI group than the 
CABG group (26.9% vs. 12.9%; p = 0,039). 
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Among 67 PCI treated patients, 46 patients 
(68.6%) received DES, 16 patients (23.9%) received 
BMS, and only 5 patients (7.5%) received balloon 
angioplasty. We tried to compare one-year MACCE 
outcome between BMS vs CABG, DES vs CABG, and 
overall PCI vs CABG. The results were shown in table 
2. No MI was documented either in the PCI, or in the 
CABG group. Composite MACCE were composed of 
death, stroke and TVR. 
In the BMS vs. CABG the composite MACCE 
were significantly higher in the BMS group (43.8% vs 
15.7%; p = 0.035). Both BMS and DES showed higher 
TVR rates as compare to CABG (18.8% vs 0.0%; p = 
0.005, and 13.0% vs 0.0%; p = 0.003, respectively). 
There were no significant differences of composite 
MACCE and death between overall PCI and CABG 
group (19.4% vs 15.7%; p = 0.570,  and 11.9% vs 
11.4%; p = 0.926, respectively). However, there were 
significant differences in proportion of stroke and 
TVR, in which proportion of stroke was significantly 
higher in the CABG group (8.6% vs 0.0%; p = 0.014), 
while proportion of  TVR was significantly higher in 
the PCI group (13.4% vs 0.0%; p = 0.001). 
After adjusment of baseline covariates, the one-year 
risk of composite MACCE and death were similar in 
the 2 groups of treatment, either using BMS, DES, or 
Table 1. Baseline Characteristics




(n = 70) p Value
Age 60 ± 8 59.8 ± 7.8 61.1 ± 8.1 0.419
Male 123 (89.8%) 61 (91.0%) 62 (88.6%) 0.633
Medical history:
Diabetes mellitus 59 (43.1%) 22 (32.8%) 37 (52.9%) 0.018*
Hipertension 111 (81.0%) 44 (82.1%) 56 (80.0%) 0.755
Dyslipidemia 98 (71.5%) 43 (64.2%) 55 (78.6%) 0.062
Current smoker 77 (56.2%) 36 (53.7%) 41 (58.6%) 0.568
Previous coronary intervention 27 (19.7%) 18 (26.9%) 9 (12.9%) 0.039*
Previous myocardial infarction 68 (49.6%) 29 (43.3%) 39 (55.7%) 0.146
Previous congestive heart failure 27 (19.7%) 10 (14.9%) 17 (24.3%) 0.169
Cerebrovascular disease 10 (7.3%) 4 (6.0%) 6 (8.6%) 0.745
Chronic kidney disease 48 (35.0%) 24 (35.8%) 24 (34.3%) 0.851
Ejection fraction  ≤ 35% 19 (14.2%) 9 (14.1%) 10 (14.3%) 0.970
Atrial fibrillation rhythm 8 (5.8%) 5 (7.5%) 3 (4.3%) 0.487
Clinical indication:
Silent ischemia 1 (0.7%) 1 (1.5%) 0 (0.0%) 0.333
Chronic stable angina 103 (75.2%) 47 (70.1%) 56 (80.0%)
Unstable angina 9 (6.6%) 5 (7.5%) 4 (5.7%)
NSTEMI 16 (11.7%) 11 (16.4%) 5 (7.1%)
STEMI 8 (5.8%) 3 (4.5%) 5 (7.1%)
Involved location 
Ostial / Mid 20 (14.6%) 9 (13.4%) 11 (15.7%) 0.705
Distal / Bifurcation 117 (85.4%) 58 (86.6%) 59 (84.3%)
Extent of disease
LM only 2 (1.5%) 2 (3.0%) 0 (0.0%) 0.001*
LM plus single vessel disease 17 (12.4%) 12 (17.9%) 5 (7.1%)
LM plus double vessel disease 33 (24.1%) 23 (34.3%) 10 (14.3%)
LM plus triple vessel disease 85 (62.0%) 30 (44.8%) 55 (78.6%)
Right coronary artery disease 97 (70.8%) 35 (52.2%) 62 (88.6%) <0.001*
SYNTAX score 34.4 ± 8.0 30.6 ± 9.3 37.9 ± 10.0 <0.001*
Note: Continues data were described using mean ± SD or median (min-max) when appropriate. As for categorical data, the data were described using percent-
age. Significancies for continues data were analyzed using Student T-test analysis or Mann-Whitney analysis and considered significant if  p < 0.05. Categorical 
data were compared using the Chi-square analysis and considered significant if p < 0.05.
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overall PCI, as can be seen in table 3. However, there 
was a trend toward higher rate of composite MACCE 
and death in the BMS group than the CABG group. 
By contrast when comparing DES vs CABG, there 
was a trend toward lower rate of composite MACCE 
and death in the DES group than the CABG group. 
The risks of stroke and TVR could not be computed 
by multivariate analysis since there was no stroke event 
in the PCI group, and no TVR event in the CABG 
group. 
Some patient’s baseline characteristics showed 
significant proportion differences in relation with 
MACCE outcome. They were age (59.5+7.4 vs 
65.0+9.1; p = 0.003), previous myocardial infarction 
(MI) history (43.4% vs 79.2%; p = 0.001), previous 
congestive heart failure (CHF) history (15.0% vs 
41.7%; p = 0.008), cerebrovascular disease (CVD) 
(4.4% vs 20.8%, p = 0.015), chronic kidney disease 
(CKD) (30.1% vs 58.3%; p = 0.008), and ejection 
fraction (EF) less than 35% (9.1% vs 37.5%, p = 
0.001). (Table 4)
However, in multivariate Cox Regression analysis, 
after adjustment with age and sex, there was no any 
variable which significantly predicted the one-year 
MACCE outcome. (Table 5)
Using Kaplan Meier analysis (figure 1), the uni-
variate survival curve for composite MACCE outcome 
and death did not differ significantly (p log rank = 









PCI vs. CABG (n=137)
Composite MACCE 1.229 (0.551 – 2.744) 0.614 1.267 (0.567 – 2.829) 0.564
Death 1.041 (0.391 – 2.775) 0.935 1.080 (0.405 – 2.878) 0.878
Stroke 0.016 (0.00 – 11.295) 0.216 NA NA
TVR 68.22 (0.32 – 14543.3) 0.123 NA NA
BMS vs. CABG (n=86)
Composite MACCE 2.998 (1.161 – 7.742) 0.023* 2.433 (0.934 – 6.342) 0.069
Death 2.904 (0.949 – 8.884) 0.062 2.439 (0.794 – 7.498) 0.120
Stroke 0.037 (0.000 – 375.9) 0.484 NA NA
TVR NA NA NA NA
DES vs. CABG (n=116)
Composite MACCE 0.811 (0.300 – 2.192) 0.679 0.887 (0.328 – 2.403) 0.814
Death 0.560 (0.149 – 2.110) 0.391 0.608 (0.160 – 2.306) 0.465
Stroke 0.021 (0.000 – 18.20) 0.264 NA NA
TVR 103.9 (0.116 – 93503) 0.181 NA NA
*Hazard ratios (HRs) are for the PCI group, as compared with CABG group. 
Table 2. MACCE Outcome Comparison
Outcome
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Table 5. Multivariate Analysis of Factors Associated with MACCE Outcome
Variables
Unadjusted HR Adjusted HR
HR (95% C.I.) p Value HR (95% C.I.) p Value
Current smoker 1.766 (0.691 – 4.518) 0.235 1.473 (0.567 – 3.826) 0.427
Previous myocardial infarction 2.951 (1.014 – 8.588)* 0.047* 2.796 (0.970 – 8.055) 0.057
Previous congestive heart failure 1.272 (0.342 – 4.722) 0.720 1.134 (0.314 – 4.089) 0.848
Ejection fraction  ≤35% 1.911 (0.509 – 7.175) 0.338 2.102 (0.565 – 7.827) 0.268
Cerebrovascular disease 2.438 (0.843 – 7.047) 0.100 1.996 (0.680 – 5.863) 0.209
Chronic kidney disease 2.183 (0.910 – 5.236) 0.080 1.683 (0.653 – 4.336) 0.281
Atrial fibrillation rhythm 4.026 (1.043 – 15.547)* 0.043* 2.551 (0.624 – 10.424) 0.192
SYNTAX score 1.019 (0.976 – 1.063) 0.394 1.022 (0.980 – 1.067) 0.311
Variables included in multivariate analysis were variables with p < 0.2 in univariate analysis. Adjusted HR: variables were adjusted with age and sex. The analysis 
were conducted using Cox Regression analysis with level of significance p < 0.05 (mark with *). 







Age 59.5 ± 7.4 65.0 ± 9.1 0.003*
Male 99 (87.6%) 24 (100%) 0.129
Medical history:
Diabetes mellitus 51 (45.1%) 8 (33.3%) 0.289
Hipertension 93 (82.3%) 18 (75.0%) 0.400
Dyslipidemia 81 (71.7%) 17 (70.8%) 0.933
Current smoker 60 (53.1%) 17 (70.8%) 0.112
Previous coronary intervention 21 (18.6%) 6 (25.0%) 0.572
Previous myocardial infarction 49 (43.4%) 19 (79.2%) 0.001*
Previous congestive heart failure 17 (15.0%) 10 (41.7%) 0.008*
Cerebrovascular disease 5 (4.4%) 5 (20.8%) 0.015*
Chronic kidney disease 34 (30.1%) 14 (58.3%) 0.008*
Ejection fraction ≤35% 10 (9.1%) 9 (37.5%) 0.001*
Atrial fibrillation rhythm 5 (4.4%) 3 (12.5%) 0.145
Clinical indication:
Silent ischemia 1 (0.9%) 0 (0.0%) 0.832
Chronic stable angina 86 (76.1%) 17 (70.8%)
Unstable angina 8 (7.1%) 1 (4.2%)
NSTEMI 12 (10.6%) 4 (16.7%)
STEMI 6 (5.3%) 2 (8.3%)
Involved location 
Ostial / Mid 15 (13.3%) 5 (20.8%) 0.347
Distal / Bifurcation 98 (86.7%) 19 (79.2%)
Extent of disease
LM only 2 (1.8%) 0 (0.0%) 0.820
LM plus single vessel disease 15 (13.3%) 2 (8.3%)
LM plus double vessel disease 27 (23.9%) 6 (25.0%)
LM plus triple vessel disease 69 (61.1%) 16 (66.7%)
Right coronary artery disease 79 (69.9%) 18 (75.0%) 0.619
SYNTAX score 33.6 ± 10.2 37.8 ± 10.2 0.064
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0.610 and p log rank = 0.935, respectively) between 
the two groups of treatment. PCI patients showed a 
significantly better stroke-free survival curve as com-
pared to CABG patients (p log rank=0.016). Whilst 
the opposite result was shown for TVR, in which 
CABG patients showed a significantly better TVR-
free survival curve as compared to PCI patients (p log 
rank=0.002).
Discussion
In this study, there were no significant differences in the 
one-year risk of composite MACCE and death between 
the PCI group and the CABG group of ULMCAD 
patients at NCCHK. However, the rate of TVR was 
significantly higher in the PCI group, either using BMS 
or DES, than in the CABG group. By contrast, the rate 
of stroke was significantly higher in the CABG group 
than in the PCI group. The Kaplan-Meier survival 
curve showed consistent results, in which the compos-
ite MACCE and death-free survival curve were similar 
for both group, whereas stroke-free survival curve was 
better in the PCI group, and TVR-free survival curve 
was better in the CABG group.
Some previous studies had shown similar results. 
The MAIN-COMPARE Registry indicated that safety 
outcomes (death or composite of death, MI, or stroke) 
were comparable between PCI and CABG group, 
whereas PCI was related to a significantly higher rate 
Figure 1. Kaplan-Meier Curves for Outcome in the Overall Patients Underwent PCI or CABG
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of TVR, either in BMS or DES group.16 The left main 
subset of SYNTAX (Synergy between PCI with Taxus 
and Cardiac Surgery) trial also reported same results, 
in which PCI was comparable with CABG in terms of 
overall MACCE, and overall safety outcomes (death, 
cerebrovascular accident, and MI). The SYNTAX 
investigators also reported a higher rate of TVR in 
the PCI group, and a higher rate of cerebrovascular 
accident in the CABG group.19
In our study with 137 patients, the one-year 
MACCE outcome are as follow: death 11.7%, MI 0.0%, 
stroke 4.4%, and TVR 6.6%. The MAIN-COMPARE 
Registry, which so far the largest and longest study 
comparing PCI and CABG in ULMCAD,  with 2.240 
patients, showed 5-year MACCE outcome as follow: 
death 14.6%, MI 1.0%, stroke 1.8%, and TVR 9.7%.16 
Though our study result could not be simply compared 
to the MAIN-COMPARE study, due to different follow 
up period and study population size, the outcome of 
the revascularization procedure for ULMCAD patients 
in our centre is seemingly to be  quite equal with other 
centres, except for a bit higher rate of stroke.
Lee et al, in comparison of CABG with PCI with 
DES for ULMCAD, indicated MI and diabetes as 
predictors of  MACCE outcome.8 The DELFT (Drug 
Eluting stent for LeFT main) Registry reported that 
age was predictor for cardiac death, while diabetes was 
predictor for MACE and TVR, and EF < 50% was 
predictor of TVR.13 In our study, patients who experi-
enced MACCE in one-year follow up were older in age, 
and showed higher proportion of previous MI, CHF, 
CVD, CKD, or EF < 35%. However, after multivariate 
analysis, none of these variables significantly predicted 
one-year MACCE outcome in this study.
Capodanno et al reported the usefulness of 
SYNTAX score to select patients with ULMCAD to 
be treated with CABG. The study concluded that a 
SYNTAX score threshold of 34 may usefully identify 
a cohort of patients with ULMCAD who benefit most 
from surgical revascularization in terms of mortality.20  
In our study, the SYNTAX score was significantly 
higher in CABG patients than in PCI patients (37.9 vs 
30.6).This may be translated that ULMCAD patients 
with lower SYNTAX score may undergo PCI with no 
difference in risk of MACCE and death as compare 
to CABG.  
The CABG group in this study showed a higher 
clinical and angiographic risk profile, which was 
indicated by higher proportion of diabetic patients, 
more severe coronary artery disease, involvement of 
RCA, and higher SYNTAX score. This data was not 
surprising, since in diabetic patients, especially those 
with more severe CAD (thus, higher SYNTAX score), 
cardiologist tend to send the patients to surgeon, as rec-
ommended by the guidelines.1 However, these factors 
did not reach statistical significancy as risk predictors 
of MACCE after multivariate analysis. Nevertheless, 
it will be wise to consider these variables when select-
ing ULMCAD patients for PCI. In terms of clinical 
practice, PCI could be considered as an effective and 
safe treatment for selected ULMCAD patients with 
lower SYNTAX score, non-diabetic, less severe coro-
nary artery disease, and RCA disease-free. 
The only higher proportion of clinical factor in 
the PCI group was previous PCI (p = 0.039). The 
PCI group also had a higher proportion of  TVR as 
compared to the CABG group. We noticed that the 
most important cause of repeated PCI in our study is 
in-stent restenosis (ISR). Mandip Singh et al reported 
that ISR at baseline was one of the clinical factors that 
was associated with increased risk of TVR in 11.484 
patients underwent PCI in PRESTO trial.21 Consider-
ing these data, PCI might be more effective (in term 
of less TVR event) in selected patients with de novo 
ULMCAD lession. Until we have a better solution to 
treat ISR (especially DES-ISR) with percutaneous in-
tervention, it might be better to consider CABG rather 
than PCI for a revascularization procedure. 
This study only analyzed the clinical variables as 
risk factors for the overall MACCE events, but not 
with each component of MACCE (death, stroke, 
MI, or TVR) separately, due to lack of sample size. 
It might be that with a bigger sample size, some vari-
ables will show significant association as risk factors 
of death, stroke, MI or TVR. Sotiris C. Stamou et al 
reported that recent myocardial infarction, diabetes, 
and atrial fibrillation (AF) was associated with higher 
risk of stroke in post CABG patients.22 In our study, 
CABG patients had higher proportion of diabetes (p 
= 0.018), whereas previous myocardial infarction and 
AF were significantly associated with higher risk of 
overall MACCE in unadjusted multivariate analysis 
(HR: 2.951; 95% CI: 1.014–8.588, p = 0.047, and 
HR: 4.026; 95% CI: 1.043–15.547, p = 0.043, re-
spectively). Stroke proportion was higher in the CABG 
group. We couldn’t conclude that diabetes, previous 
MI or AF were risk factors of stroke after CABG in 
this study, but with a bigger sample size, these factors 
might show significant relationship as risk factors of 
stroke after CABG.
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In subgroup analysis the BMS group showed a 
trend toward higher rate of MACCE outcome than 
the CABG group, whereas the DES group showed 
a trend toward lower rate of MACCE outcome than 
the CABG group. Again, these results was in line 
with other previous studies which reported that DES 
displayed a better result than BMS in ULMCAD.7-16 
In light of this result, we consider using DES, instead 
of BMS in treating ULMCAD. In the future, with 
more experiences, and with the improvement of PCI 
techniques and stent technology, hopefully TVR rate 
can also be lessen, so PCI could be a more excellent 
treatment choice for ULMCAD patients. 
Study limitation. This was a retrospective study 
with it’s inherent limitations, so despite appropriate 
statistical adjustments, unknown confounders might 
have affected the results. Lack of TVR event in the 
CABG group, and stroke event in the PCI group had 
hampered the multivariate analysis calculation. A 
longer follow up period, and bigger sample size, may 
give  a better study results.
Conclusion
In this retrospective cohort study, we found that 
PCI showed similar safety with CABG in treating 
ULMCAD, as there were no differences in one-year 
composite MACCE and death outcome between the 
two groups. However TVR rate were higher in PCI 
treated patients, whereas stroke rate were higher among 
CABG patients.  
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